Frontage Holdings Corporation, a contract research organization (CRO) providing integrated, science-driven research and development services with presence in both North America and China, has acquired ACME Bioscience through its subsidiary Frontage Laboratories, Inc.   ACME provides discovery chemistry, medicinal chemistry, process chemistry research and development, and chemical manufacturing services for worldwide biopharmaceutical companies. ACME has extensive experience in antiviral and anti...